Clinical associations of cerebrospinal fluid TMEM106B in familial and sporadic frontotemporal dementia

Source
JAMA neurology - ISSN 2168-6149-83:8 (2026) p. 778-787
Author(s)
    Molly Olzinski, Joshua Downer, Yann Cobigo, Binita Rajbanshi, Jingyao Li, Joseph Loureiro, Kathleen A. Worringer, Hilary Heuer, Peter Ljubenkov, Lawren Vandevrede, Adam Staffaroni, Argentina Lario-Lago, Dana Leichter, Amy Wolf, Amy Wise, Mark Sanderson-Cimino, Eden Barragan, Salvatore Spina, Lea T. Grinberg, William W. Seeley, Kaitlin B. Casaletto, Joel Kramer, Eliana Marisa Ramos, Daniel Geschwind, Casey Cook, Leonard Petrucelli, Leah K. Forsberg, Tania Gendron, Bradley F. Boeve, Jolien Perneel, Rosa Rademakers, Howard J. Rosen, Rowan Saloner, Adam L. Boxer, Julio C. Rojas

TMEM106B : friend or foe? From disease and risk modifier to amyloidogenic protein

Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, 2025,217 p.

Increased TMEM106B levels lead to lysosomal dysfunction which affects synaptic signaling and neuronal health

Source
Molecular neurodegeneration - ISSN 1750-1326-20:1 (2025) p. 1-26
Author(s)

White matter pathology in FTLD caused by GRN mutations

Source
Acta neuropathologica - ISSN 0001-6322-149:1 (2025) p. 1-4
Author(s)

White matter pathology in FTLD caused by GRN mutations : [supplementary material]

Source
The University of British Columbia, 2024,
Author(s)